| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 3570 |
| 1 | DUPILUMAB | 2817 |
| 2 | GLATIRAMER ACETATE | 2076 |
| 3 | TIRZEPATIDE | 2028 |
| 4 | NALTREXONE | 1927 |
| 5 | METFORMIN | 1818 |
| 6 | METFORMIN ER 500 MG | 1727 |
| 7 | METFORMIN ER 750 MG | 1727 |
| 8 | ADALIMUMAB | 1545 |
| 9 | DULAGLUTIDE | 1435 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLATIRAMER ACETATE INJECTION | 351 | 0.0745 |
| 1 | LENACAPAVIR SODIUM | 37 | 0.0731 |
| 2 | NALTREXONE | 1927 | 0.0621 |
| 3 | LANREOTIDE ACETATE | 377 | 0.0474 |
| 4 | DEOXYCHOLIC ACID | 104 | 0.0446 |
| 5 | TESTOSTERONE ENANTHATE | 61 | 0.0371 |
| 6 | GLATIRAMER ACETATE | 2076 | 0.0348 |
| 7 | RILONACEPT | 39 | 0.0337 |
| 8 | ERGOCALCIFEROL | 946 | 0.0318 |
| 9 | ARIPIPRAZOLE LAUROXIL | 145 | 0.0315 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 4111 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 3961 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2817 |
| 3 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 2028 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1677 |
| 5 | PCSK9 Inhibitor [EPC] | 1669 |
| 6 | Insulin Analog [EPC] | 1501 |
| 7 | Interferon beta [EPC] | 1284 |
| 8 | Corticosteroid [EPC] | 1102 |
| 9 | Interleukin-17A Antagonist [EPC] | 956 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenocorticotropic Hormone [EPC] | 64 | 0.0715 |
| 1 | PCSK9 Inhibitor [EPC] | 1669 | 0.0648 |
| 2 | Interleukin-5 Antagonist [EPC] | 35 | 0.0509 |
| 3 | Cytolytic Agent [EPC] | 104 | 0.0446 |
| 4 | Provitamin D2 Compound [EPC] | 946 | 0.0318 |
| 5 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 295 | 0.0286 |
| 6 | Interleukin-17A Antagonist [EPC] | 956 | 0.0256 |
| 7 | Melanocortin 4 Receptor Agonist [EPC] | 6 | 0.0211 |
| 8 | Human Immunoglobulin G [EPC] | 294 | 0.0140 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 26 | 0.0125 |